Unicycive net loss widens 147% to USD 14.55 million in FY26 first half - UNCY News | RalliesUnicycive net loss widens 147% to USD 14.55 million in FY26 first half
U
UNCY• Unicycive reports wider first-half loss and higher expenses
- Unicycive posted a GAAP net loss of USD 14.55 million for the six months ended June 30, 2026, widening 147%.
- Quarterly GAAP net loss narrowed to USD 1.72 million, swinging from USD 6.45 million a year earlier on higher other income.
- Operating loss widened 46% to USD 10.14 million, as R&D expense rose 59% to USD 2.79 million.
- General and administrative costs climbed 41% to USD 7.35 million, including a USD 0.4 million increase tied to commercial launch preparation.
- FDA issued a complete response letter for the resubmitted OLC NDA on June 30, 2026, citing the same third-party manufacturing deficiencies as 2025.
